Rated a Top 10 free iPhone app by iMedicalApps
HCV Care & Guidance
Practical Education and Resources
Table of Contents  |  CME/CE Information  | Technical Requirements  | Login
  /2037/iPhoneAd/2037iPhoneAd.gif [true]
Chapter 1
Getting Ready for Direct-Acting Antiviral (DAA) Therapy

Chapter 2
What You Need to Know About the New Direct-Acting Antiviral (DAA) Regimens

Chapter 3
Hematologic Adverse Effects

Chapter 4
Dermatologic Adverse Effects

Chapter 5
Gastrointestinal Adverse Effects

Chapter 6
Neuropsychiatric Adverse Effects

Chapter 7
Understanding Drug-Drug Interactions in this New Triple-Therapy Era

Chapter 8
Treating HCV in Special Populations

Chapter 9
Predictors of Response

Chapter 10
Treating Hepatitis C in Patients with Cirrhosis

Chapter 11
Anti-Hepatitis C Triple Therapy Update

HCV Care & Guidance HCV Care & Guidance PDF Print PDF Print
HCV Care & Guidance

iPhone App

This CME/CE activity has expired for credit.
Click here to view our current activities in Gastroenterology.

ACCME Disclaimer
Chapter 11 – Anti-Hepatitis C Triple Therapy Update

Contributing Faculty
Sherilyn C. Brinkley Sherilyn C. Brinkley, MSN, CRNP
Nurse Practitioner/ Program Manager
Infectious Disease Department
Johns Hopkins University
Baltimore, Maryland

Activity Goal
The goal of this activity is to address the needs of nurse practitioners and physician assistants for information and practical instruction regarding new direct-acting antiviral (DAA) therapies for hepatitis C and their integration into clinical practice.

Target Audience
This CME/CE activity have been designed for nurses, nurse practitioners, physician assistants, caseworkers, hepatologists, gastroenterologists, infectious disease specialists, primary care physicians, internists, family medicine physicians, obstetrician/gynecologists and other clinicians involved in the care of patients with HCV.

Learning Objective
Consider new efficacy and safety data and labeling changes related to first-generation protease inhibitor triple therapy in order to optimize the likelihood of treatment success in patients with chronic hepatitis C.


CME Information: Physicians
Statement of Accreditation
Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Projects In Knowledge® designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Information: Nurses
Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Upon completion of this course, participants will be awarded 1.17 nursing contact hour(s).

Joint Accreditation Nursing Provider Number: 4008235

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, or PIK endorsement of any commercial product or service.


Disclosure Information
The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Sherilyn C. Brinkley, MSN, CRNP, has received honoraria from Genentech Inc, Merck & Co., Inc, and Vertex Pharmaceuticals Incorporated; and has received consulting fees from Merck & Co., Inc, and Vertex Pharmaceuticals Incorporated.

Nancy J. Nordenson, MFA, MT (ASCP) (medical writer) has disclosed no significant relationships.

Off-Label Statement
This chapter includes no off-label discussion of anti-HCV therapies.

Peer Reviewer has disclosed no significant relationships.

Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no significant relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no significant relationships to disclose.

Projects In Knowledge’s staff members have no significant relationships to disclose.


Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

Contract for Mutual Responsibility in CME/CE
Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

top 2163.02

Launch Activity

Projects In Knowledge®

Peer Reviewed

Vertex Pharmaceuticals

Release Date: May 29, 2013.

Termination Date: May 28, 2014.

Estimated time for completion of this activity:
CME: 1.00 hour
CNE: 1.17 hours

CME/CE Instructions
To obtain CME/CE credit for this activity:
  1. Read the chapter carefully.
  2. Complete/submit the posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.

For questions about content or obtaining CME credit, please contact us.


Copyright © 1997-2020, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE and LIVING MEDICAL ETEXTBOOK are registered trademarks of Projects In Knowledge, Inc.
PROJECTS IN KNOWLEDGE • 290 W. Mt. Pleasant Avenue, Suite 2350 • Livingston, New Jersey 07039 (973) 890-8988